UBC-led biomedical innovation hub to accelerate development and manufacturing of lifesaving medicines for Canadians
Canada’s biotech ecosystem is poised for a major boost with the federal government announcement today that B.C. will be home to Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH).
Mar 15, 2023
About Canada’s Immuno-Engineering and Biomanufacturing Hub
Canada’s Immuno-Engineering and Biomanufacturing Hub brings together a multi-disciplinary, multisectoral coalition of more than 50 partner institutions (9 academic, 15 private, 6 public, 4 other research organizations, 16 not-for-profit) from […]
Mar 15, 2023
Event: New UBC-led national research hub to accelerate Canada’s vaccine and therapeutics production
The University of British Columbia is receiving federal funding for a new research hub that will improve pandemic readiness and the overall health and well-being of Canadians.
Mar 14, 2023
From COVID-19 to the common cold: UBC scientists identify broadly effective, infection-halting compound
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
Dec 14, 2022
Catching COVID-19 during pregnancy increases risk of hospitalization, premature birth: national study
As Canada faces a sixth wave of COVID-19 infections, researchers at the UBC faculty of medicine are urging people who are pregnant to remain vigilant based on data from Canada’s first national, peer-reviewed study on COVID-19 in pregnancy.
May 2, 2022
Dr. Pieter Cullis named 2022 Canada Gairdner Award laureate
UBC professor Dr. Pieter Cullis has been named a 2022 Canada Gairdner International Award laureate for his pioneering work developing the lipid nanoparticle delivery technology that enables mRNA therapeutics such as the highly effective COVID-19 mRNA vaccines.
Apr 5, 2022
New nasal spray treats Delta variant infection in mice, indicating broad spectrum results
Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.
Mar 28, 2022
Microbe-slaying copper applied to UBC buildings
More than 400 sanitizing copper patches have been added to high-contact areas at UBC as part of a collaboration between Teck Resources and UBC to study the antimicrobial properties of copper.
Mar 28, 2022
British Columbians worried pandemic will never end, and climate change is only adding to the fear
If you’re feeling like the pandemic is never-ending, you’re not alone. Sixty-four per cent of British Columbians are worried the COVID-19 pandemic will be around for years to come, with concerns about climate change adding fuel to the fire.
Mar 1, 2022
New COVID-19 study links nurses’ mental health to quality of care
Stories of stress and burnout among healthcare workers, particularly nurses, continue to make news during the COVID-19 pandemic.
Now, new research shows these mental health problems could be contributing to decreased quality of patient care.
Feb 16, 2022
Futuristic coating for hospital fabrics and activewear kills COVID and E. coli
UBC researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
Feb 10, 2022
UBC-led research team finds nine new coronavirus species
A former UBC post-doctoral research fellow led an international research team in re-analyzing all public RNA sequencing data to uncover almost ten times more RNA viruses than were previously known, including several new species of coronaviruses in some unexpected places.
Jan 26, 2022
UBC clinical trial supports new self-administered rapid antigen test
Thanks to new research compiled with data from UBC’s first on-campus clinical study, a new self-administered rapid antigen test will soon be available in Canada. It’s a tool that could help combat growing uncertainty, prevent transmission and potentially save lives.
Dec 23, 2021
UBC scientists unveil world’s first molecular-level analysis of Omicron variant spike protein
UBC researchers are the first in the world to conduct a molecular-level structural analysis of the Omicron variant spike protein.
Dec 22, 2021
Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.
Dec 1, 2021
UBC scholars call for global research agenda into TikTok’s impacts on public health
TikTok has acquired more than one billion monthly users in just five years, but the influential video-sharing app remains one of the least studied social media platforms around. In this Q&A, UBC researchers Dr. Skye Barbic and UBC research associate Marco Zenone discuss the need for a global research agenda into TikTok’s impact on public health.
Nov 25, 2021
Heightened food worries linked to worse mental health during COVID-19 pandemic
The COVID-19 pandemic and its associated lockdowns may have worsened worries over food insecurity among many Canadians and negatively impacted their mental health, according to a nationwide survey conducted during the first wave.
Sep 23, 2021
How to make the transition back to the office easier on your pandemic pet
After more than a year of working and schooling from home, many offices and schools are re-opening as the COVID-19 vaccine uptake rises.
Sep 14, 2021
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
Aug 4, 2021
Virtual contact in pandemic prompts over 60s’ loneliness
Older adults who had more virtual contact than their peers during the pandemic actually experienced increased loneliness, according to new research published today.
Jul 26, 2021